Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Veterinary Oncology Market to reach USD 461.59 million by 2028.

Global Veterinary Oncology Market Size study, by Therapy (Surgery, Radiotherapy, Chemotherapy, Immunotherapy, Others) by Animal type (Canine, Feline) by Cancer Type (Lymphoma, Mast Cell Cancer, Mammary and Squamous Cell Cancer, Others) and Regional Forecasts 2022-2028

Product Code: HLSDT-47429766
Publish Date: 9-06-2022
Page: 200

Global Veterinary Oncology Market is valued approximately USD 207.5 million in 2021 and is anticipated to grow with a healthy growth rate of more than 12.1% over the forecast period 2022-2028. Veterinary oncology is the treatment of cancer-stricken pets in order to improve their quality of life. One of the most common causes of mortality in pets is cancer. Skin cancer and bone cancer are more common in dogs and cats. Due to constant exposure of animal skin to UV rays, skin tumors are the most prevalent and often diagnosed cancer in domestic animals. Veterinarians utilize the HHHHHMM scale to assess the quality of life of pet owners before making treatment decisions for diseases like cancer. The rising prevalence of cancer in the pet population, together with the increased use of veterinary cancer therapy as a treatment strategy, is driving market expansion. Another element driving market expansion is the global use of canine cancer registry to quantify cancer incidences. According to Frontiers in Veterinary Science in February 2019, The Swiss Canine Cancer Registry (SCCR) was used as a data source and was developed for future comparison research of canine and human cancers.. This database is also useful in reducing the occurrence of malignant tumours in the human population, resulting in market expansion. Researchers working on veterinary oncology studies are helping to propel the veterinary oncology market forward. For example, the University of Illinois conducted a study in August 2017 that involved more precise identification of metastasis (cancer spread throughout the body) in dogs with head and neck cancers. Furthermore, market participants are concentrating on new product development and strategic partnerships. For example, in 2018, AdvaVet, an Oasmia Pharmaceutical AB company, launched XR17 technology, which is based on nanoparticle formulation and makes a single Active Pharmaceutical Ingredient (API) or numerous APIs water soluble. It is a combined therapy that is also used to treat a variety of cancer conditions in pets. Major drivers driving the market are increased expenditure on animal healthcare in developed economies due to rising willingness to spend on pet healthcare by owners and government initiatives for veterinary cancer treatment. In addition, the American Veterinary Medical Association (AVMA) predicted in October 2019 that one out of every four dogs may have neoplasia at some point in their lifetimes. However, the high cost of veterinary cancer therapy, as well as side effects of oncology medications including as hair loss, decreased appetite, and vomiting, will stifle market expansion between 2022 and 2028.

The key regions considered for the global Veterinary Oncology Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the veterinary oncology market. Over the forecast period, the segment is expected to dominate the market. The growing focus on pet health, the presence of a large number of pet medicine manufacturing companies, and the rapid acceptance of novel pet care medications are all contributing to market growth. Furthermore, the government’s increased support for pet oncology treatment in this region, as well as the existence of market behemoths in the oncology market, are boosting the market. The market in Asia Pacific is likely to develop over the forecast period as veterinarians become more aware of various treatment procedures for pets, veterinary healthcare infrastructure improves, and animal healthcare expenditure rises.

Major market player included in this report are:
PetCure Oncology
Zoetis
Karyopharm Therapeutics, Inc.
Varian Medical Systems
Accuray Incorporated
Boehringer Ingelheim GmbH
Elanco
One Health
Regeneus Ltd.
Morphogenesis, Inc
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal type:
Canine
Feline
By Cancer Type:
Lymphoma
Mast Cell Cancer
Mammary and Squamous Cell Cancer
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Veterinary Oncology Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Veterinary Oncology Market, by Region, 2020-2028 (USD Million)
1.2.2. Veterinary Oncology Market, by Therapy, 2020-2028 (USD Million)
1.2.3. Veterinary Oncology Market, by Animal Type, 2020-2028 (USD Million)
1.2.4. Veterinary Oncology Market, by Cancer Type, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Veterinary Oncology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Veterinary Oncology Market Dynamics
3.1. Veterinary Oncology Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing pervasiveness of cancer in the pet population
3.1.1.2. Growing expenditure on animal healthcare
3.1.2. Market Challenges
3.1.2.1. High cost of veterinary cancer therapy
3.1.2.2. Side effects of oncology medications including as hair loss, decreased appetite, and vomiting
3.1.3. Market Opportunities
3.1.3.1. Increasing number of veterinary clinical studies for evaluating safety and efficacy of different oncologic treatments in pets.
3.1.3.2. Supportive government initiatives pertinent to veterinary cancer treatment
Chapter 4. Global Veterinary Oncology Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Veterinary Oncology Market, by Therapy
6.1. Market Snapshot
6.2. Global Veterinary Oncology Market by Therapy, Performance – Potential Analysis
6.3. Global Veterinary Oncology Market Estimates & Forecasts by Therapy 2018-2028 (USD Million)
6.4. Veterinary Oncology Market, Sub Segment Analysis
6.4.1. Surgery
6.4.2. Radiotherapy
6.4.3. Chemotherapy
6.4.4. Immunotherapy
6.4.5. Others
Chapter 7. Global Veterinary Oncology Market, by Animal Type
7.1. Market Snapshot
7.2. Global Veterinary Oncology Market by Animal Type, Performance – Potential Analysis
7.3. Global Veterinary Oncology Market Estimates & Forecasts by Animal Type 2018-2028 (USD Million)
7.4. Veterinary Oncology Market, Sub Segment Analysis
7.4.1. Canine
7.4.2. Feline
Chapter 8. Global Veterinary Oncology Market, by Cancer Type
8.1. Market Snapshot
8.2. Global Veterinary Oncology Market by Cancer Type, Performance – Potential Analysis
8.3. Global Veterinary Oncology Market Estimates & Forecasts by Cancer Type 2018-2028 (USD Million)
8.4. Veterinary Oncology Market, Sub Segment Analysis
8.4.1. Lymphoma
8.4.2. Mast Cell Cancer
8.4.3. Mammary and Squamous Cell Cancer
8.4.4. Others
Chapter 9. Global Veterinary Oncology Market, Regional Analysis
9.1. Veterinary Oncology Market, Regional Market Snapshot
9.2. North America Veterinary Oncology Market
9.2.1. U.S. Veterinary Oncology Market
9.2.1.1. Therapy breakdown estimates & forecasts, 2018-2028
9.2.1.2. Animal Type breakdown estimates & forecasts, 2018-2028
9.2.1.3. Cancer Type breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Veterinary Oncology Market
9.3. Europe Veterinary Oncology Market Snapshot
9.3.1. U.K. Veterinary Oncology Market
9.3.2. Germany Veterinary Oncology Market
9.3.3. France Veterinary Oncology Market
9.3.4. Spain Veterinary Oncology Market
9.3.5. Italy Veterinary Oncology Market
9.3.6. Rest of Europe Veterinary Oncology Market
9.4. Asia-Pacific Veterinary Oncology Market Snapshot
9.4.1. China Veterinary Oncology Market
9.4.2. India Veterinary Oncology Market
9.4.3. Japan Veterinary Oncology Market
9.4.4. Australia Veterinary Oncology Market
9.4.5. South Korea Veterinary Oncology Market
9.4.6. Rest of Asia Pacific Veterinary Oncology Market
9.5. Latin America Veterinary Oncology Market Snapshot
9.5.1. Brazil Veterinary Oncology Market
9.5.2. Mexico Veterinary Oncology Market
9.6. Rest of The World Veterinary Oncology Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. PetCure Oncology
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Therapy Summary
10.2.1.5. Recent Developments
10.2.2. Zoetis
10.2.3. Karyopharm Therapeutics, Inc.
10.2.4. Varian Medical Systems
10.2.5. Accuray Incorporated
10.2.6. Boehringer Ingelheim GmbH
10.2.7. Elanco
10.2.8. One Health
10.2.9. Regeneus Ltd.
10.2.10. Morphogenesis, Inc
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now